Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Synthetic Blood Substitutes And Blood Products Market Size Changed, over the years?
The market for synthetic blood substitutes and blood products has experienced significant growth in recent years. It’s projected to increase from a value of $6.55 billion in 2024 to $7.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 16.3%. Factors such as the rise in the elderly population, growing need for blood transfusions, heightened demand for clean and contamination-free blood, rising consciousness about risks associated with blood transfusion, and amplified emphasis on emergency healthcare have contributed to the growth seen in the historical period.
How Much Will the Synthetic Blood Substitutes And Blood Products Market Be Worth in 2029?
In the coming years, the market for synthetic blood substitutes and blood products is projected to undergo swift expansion. The market is anticipated to climb to $13.76 billion by 2029, witnessing a compound annual growth rate (CAGR) of 15.9%. The projected growth over the forecast duration can be associated with the broadening scope in military and disaster response, heightened consciousness about alternative blood substitutes, an upsurge in the prevalence of blood-related disorders, and an escalating number of trauma and emergency surgeries. Notable trends expected within the forecast timeline encompass the creation of hemoglobin-based oxygen carriers, regulatory clearances and ongoing research, strides in biotechnology, advancements in the field of regenerative medicine, and the incorporation of artificial intelligence (AI).
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21294&type=smp
Which is the Largest Company in the Synthetic Blood Substitutes And Blood Products Market?
Major companies operating in the synthetic blood substitutes and blood products market are Takeda Pharmaceutical Company Limited, Fresenius Kabi AG, Baxter International Inc., Octapharma AG, Green Cross Corporation, Alliance Pharmaceutical Corporation, Hemosol Inc., Sanguine Corporation, Sangart Inc., Biopure Corporation, Tenex Therapeutics, Velico Medical, Hemarina S.A., KaloCyte Inc., Aurum Biosciences Limited, SpheriTech Limited, Dendritech Inc., HbO2 Therapeutics LLC, HemoBioTech Inc., Somatogen Inc.
What Are the Main Market Drivers in the Synthetic Blood Substitutes And Blood Products Industry?
The synthetic blood substitutes and blood products market is anticipated to expand due to the growing incidence of chronic illnesses. Chronic conditions are those that are enduring and manageable but are not curable, usually persisting for over a year and necessitating continuous medical care. The escalation in the rate of such ailments can be ascribed to multiple factors such as an aging population, unhealthy lifestyles, and longer lifespan. Synthetic blood substitutes and blood products have a crucial part in controlling the rates of chronic diseases by addressing particular challenges such as blood loss, anemia, and organ function, which are prevalent in patients with chronic conditions. For example, data from the Australian Institute of Health and Welfare, a government agency in Australia, revealed that in June 2024, the death rate from chronic diseases in Australia rose from 459 per 100,000 individuals in 2021 to 490 in 2022. Hence, the increasing incidence of chronic illnesses propels the growth of the synthetic blood substitutes and blood products market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21294&type=smp
How Is the Synthetic Blood Substitutes And Blood Products Market Segments Structured?
The synthetic blood substitutes and blood products market covered in this report is segmented –
1) By Type: Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander
2) By Application: Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Other Applications
3) By End-User: Hospitals And Clinics, Blood Banks, Other End users
Subsegments:
1) By Perfluorocarbon Based Product (PFC): Emulsion-Based Products, Non-Emulsion-Based Products
2) By Haemoglobin Based Oxygen Carrier: Polymerized Hemoglobin-Based Products, Crosslinked Hemoglobin-Based Products
3) By Synthetic Platelet: Platelet Substitutes, Platelet Aggregation Inhibitors
4) By Recombinant Factor: Recombinant Factor VIII, Recombinant Factor IX, Other Recombinant Factors
5) By Blood Expander: Colloid Solutions, Crystalloid Solutions
What Strategic Trends Are Transforming the Synthetic Blood Substitutes And Blood Products Market?
Leading businesses in the synthetic blood substitutes and blood product market are prioritizing the creation of cutting-edge solutions, like lab-grown blood vessels. These efforts aim to advance emergency healthcare, improve trauma therapy results, and tackle the worldwide shortage of donor blood and tissues. Lab-created blood vessels are man-made blood channels derived from human or synthetic cells, intended to mimic the structure and performance of natural arteries and veins. Their use spans diverse medical fields like trauma repair, dialysis, and cardiovascular surgery. For example, Humacyte Global, Inc., a clinical stage biotechnology platform firm based in the U.S., gained U.S. Food and Drug Administration (FDA) endorsement for Symvess in December 2024. Symvess is a bioengineered blood vessel implant intended for trauma occupants in urgent need of revascularization. This product provides a safer substitute to vein harvesting or synthetic grafts and is crafted for universal application. It aids in reinstating blood circulation and preserving limbs post severe trauma.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Synthetic Blood Substitutes And Blood Products Market?
North America was the largest region in the synthetic blood substitutes and blood products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic blood substitutes and blood products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21294
This Report Delivers Insight On:
1. How big is the synthetic blood substitutes and blood products market, and how is it changing globally?
2. Who are the major companies in the synthetic blood substitutes and blood products market, and how are they performing?
3. What are the key opportunities and risks in the synthetic blood substitutes and blood products market right now?
4. Which products or customer segments are growing the most in the synthetic blood substitutes and blood products market?
5. What factors are helping or slowing down the growth of the synthetic blood substitutes and blood products market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model